1. Others

Others

There are a number of inhibitors, agonists, and antagonists which we cannot make precise classification because the research area is still unknown.

Others Related Products (73928):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-145995
    CS12192 1888318-68-0 98%
    CS12192 is a compound improving survival and weight gain. CS12192 has the potential for the research of graft-versus-host disease (GVHD) (extracted from the patent CN112773802A).
    CS12192
  • HY-146056
    Anabolic agent-1 2439179-74-3 98%
    Compounds, as a new type of bone morphogenetic protein-2 up regulator, can not only correct the bone loss in patients, but also have a wide range of clinical applicability.
    Anabolic agent-1
  • HY-14605S
    Rasagiline-13C3 mesylate 1391052-18-8 98%
    Rasagiline-13C3 ((R)-AGN1135-13C3; TVP1012-13C3) mesylate is the deuterium labeled Rasagiline (mesylate) (HY-14605). Rasagiline (R-AGN1135) mesylate is a highly potent selective irreversible mitochondrial monoamine oxidase (MAO) inhibitor with IC50s of 4.43 nM and 412 nM for rat brain MAO B and A activity, respectively.
    Rasagiline-13C3 mesylate
  • HY-146102
    M1 ligand 1 2479356-53-9 98%
    M1 ligand 1 (compound 3b-b) is a muscarinic acetylcholine receptor M1 ligand. M1 ligand 1 is a N-desmethyl congener of arecoline derivative. M1 ligand 1 can be used as PET (positron emission tomography) radiotracer.
    M1 ligand 1
  • HY-146152
    ASGPR modulator-1 2052968-88-2 98%
    ASGPR modulator-1 (Compound 5TJX) is a macrocycle compound that can be uesd for protein-protein interaction study.
    ASGPR modulator-1
  • HY-146202
    PDE4B/7A-IN-2 2511632-55-4 98%
    5-HT1A/5-HT7 receptor antagonist (5-HT1A Ki = 8 nM, Kb = 0.04 nM; 5-HT7 Ki = 451 nM, Kb = 460 nM) with PDE4B/PDE7A inhibitory activity (PDE4B IC50 = 80.4 μM; PDE7A IC50 = 151.3 μM) , its antidepressant like effect is stronger than that of escitalopram as a reference agent.
    PDE4B/7A-IN-2
  • HY-146232
    F 13714 208109-38-0 98%
    F 13714 (F 14679) is a prototypical 5-HT1A agonist with a pKi of 10.23. F 13714 induces large Ca2+ responses.
    F 13714
  • HY-146259
    hCAIX/XII-IN-4 1119200-33-7 98%
    hCAIX/XII-IN-4 (compound 6c) is a potent CAIX/XII inhibitor with the Ki values of 4.5 nM, 23.6 nM, >10000 nM and >10000 nM for CAXII, CAIX, CAI and CAⅡ, respectively.
    hCAIX/XII-IN-4
  • HY-146279S
    Amino-2-deoxy-D-galactose-15N hydrochloride 478518-55-7 98%
    Amino-2-deoxy-D-galactose-15N (hydrochloride) is the 15N labeled Amino-2-deoxy-D-galactose hydrochloride.
    Amino-2-deoxy-D-galactose-15N hydrochloride
  • HY-146305
    α-Glucosidase-IN-4 2410538-67-7 99.05%
    α-Glucosidase-IN-4 is a reversible and mixed type α-glucosidase inhibitor with an IC50 of 12.98 μM, a KI of 27.02 μM, and a KIS of 13.65 μM, respectively.
    α-Glucosidase-IN-4
  • HY-146410
    AT2R antagonist 1 2709031-17-2 98%
    AT2R antagonist 1 (compound 21) is a potent and high selective AT2R (angiotensin II AT2 receptor) ligand. AT2R antagonist 1 exhibits a fair AT2R affinity, with a Ki of 29 nM. AT2R antagonist 1 also inhibits common agent-metabolizing CYP enzymes. AT2R antagonist 1 shows high stability in human, rat and mouse liver microsomes.
    AT2R antagonist 1
  • HY-146431
    AT1R antagonist 1 2848719-80-0 98%
    AT1R antagonist 1 (compound 10) is a potent AT1R selective ligand. AT1R antagonist 1 exhibits a fair AT1R affinity, with a Ki of 8.5 nM.
    AT1R antagonist 1
  • HY-146436
    AT1R antagonist 2 2848719-76-4 98%
    AT1R antagonist 2 (compound 6) is a potent AT1R selective ligand. AT1R antagonist 2 exhibits a fair AT1R affinity, with a Ki of 26 nM.
    AT1R antagonist 2
  • HY-146477S
    Hydroxy Bezafibrate-d6 2673270-01-2 98%
    Hydroxy Bezafibrate-d6 is the deuterium labeled Hydroxy Bezafibrate.
    Hydroxy Bezafibrate-d6
  • HY-146484S
    Flunisolide acetate-d6 98%
    Flunisolide acetate-d6 is the deuterium labeled Flunisolide acetate.
    Flunisolide acetate-d6
  • HY-146485S
    Fulvestrant-9-sulfone-d3 98%
    Fulvestrant-9-sulfone-d3 is the deuterium labeled Fulvestrant-9-sulfone.
    Fulvestrant-9-sulfone-d3
  • HY-146526S
    3-Hydroxy detomidine-15N2,d2 hydrochloride 1346603-61-9 98%
    3-Hydroxy detomidine-15N2,d2 (hydrochloride) is the deuterium and 15N labeled (3-((1H-Imidazol-5-yl)methyl)-2-methylphenyl)methanol hydrochloride (HY-W702768).
    3-Hydroxy detomidine-15N2,d2 hydrochloride
  • HY-14654B
    Aspirin DL-lysine 62952-06-1 98%
    Aspirin DL-lysine (ASA DL-lysine) is a lysine-containing aspirin derivative. Aspirin DL-lysine inhibits cyclooxygenase (COX) in platelets, blocks the synthesis of thromboxane A2 (TXA2), and thus inhibits platelet aggregation and activation. Aspirin DL-lysine can be used to study thrombin generation in patients with unstable angina pectoris.
    Aspirin DL-lysine
  • HY-146600S
    Hydroxyfenbendazole-d3 1596803-40-5 98%
    Hydroxyfenbendazole-d3 is the deuterium labeled Hydroxyfenbendazole.
    Hydroxyfenbendazole-d3
  • HY-146629S
    4-Methoxy estrone-d4 98%
    4-Methoxy estrone-d4 is the deuterium labeled 4-Methoxy estrone.
    4-Methoxy estrone-d4